Differential clinical effects of fluvoxamine by the effect of age in Japanese female major depressive patients
Hisashi Higuchi1, Kazuhiro Sato2, Shingo Naito3, Keizo Yoshida4, Hitoshi Takahashi5, et al1Department of Neuropsychiatry, St Marianna University School of Medicine, 2-16-1 Sugou, Miyamae-ku, Kawasaki City, Kanagawa 216-8511, Japan; 2Department of Psychiatry, Akita Kaiseikai Hospital, 1-7-5 Ushijima-...
Enregistré dans:
Auteurs principaux: | Hisashi Higuchi, Kazuhiro Sato, Shingo Naito, Keizo Yoshida, Hitoshi Takahashi, et al |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2009
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/843b4a99151b48f4959efba9700773d5 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Influence of serotonergic/noradrenergic gene polymorphisms on nausea and sweating induced by milnacipran in the treatment of depression
par: Hisashi Higuchi, Hitoshi Takahashi, et autres
Publié: (2009) -
Influence of fluvoxamine on plasma interleukin-6 or clinical improvement in patients with major depressive disorder
par: Yoshimura R, et autres
Publié: (2017) -
Post-marketing observational program of the effectiveness of fluvoxamine for the treatment of depression in patients with neurological disorders: the FRIENDS study
par: Yahno NN, et autres
Publié: (2017) -
Predisposition for borderline personality disorder with comorbid major depression is associated with that for polycystic ovary syndrome in female Japanese population
par: Kawamura S, Maesawa C, Nakamura K, Nakayama K, Morita M, Hiruma Y, Yoshida T, Sakai A, Masuda T
Publié: (2011) -
The Effect Of Fluvoxamine On Sleep Architecture Of Depressed Patients With Insomnia: An 8-Week, Open-Label, Baseline-Controlled Study
par: Hao Y, et autres
Publié: (2019)